Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus

Keyphrases

• AIDS/HIV 100%
• Highly Active Antiretroviral Therapy (HAART) 100%
• Cardiovascular Prevention 100%
• Cardiovascular Therapy 100%
• Blood Pressure 33%
• Life Expectancy 33%
• Quality of Life 33%
• Cardiovascular Disease 33%
• HIV Patients 33%
• Lifestyle Intervention 33%
• Glucose Metabolism 33%
• Antiretroviral Therapy 33%
• Lipid Metabolism 33%
• Pharmacologic Interventions 33%
• HIV Infection 33%
• Cardiovascular Complications 33%
• CVD Prevention 33%
• Healthcare Investment 33%
• HIV-infected Patients 33%
• Causes of Mortality 33%
• Cardiovascular Risk Factors 33%
• Prolonged Use 33%
• Metabolic Adverse Events 33%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Cardiovascular Disease 100%
• Life Expectancy 20%
• Adverse Event 20%
• Cardiovascular Risk 20%
• Atherosclerosis 20%
• Human Immunodeficiency Virus Infection 20%
• Lipid 20%
• Glucose 20%

Immunology and Microbiology

• Human Immunodeficiency Virus 100%
• Cardiovascular System 100%
• Lipid Metabolism 20%
• Glucose Metabolism 20%
• Blood Pressure 20%
• Human Immunodeficiency Virus Infection 20%
• Atherosclerosis 20%
• Life Expectancy 20%